Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2)

被引：0
|
作者：
Mease, P. [1 ,2 ]
Kirkham, B. [3 ]
McInnes, I. B. [4 ]
Kremer, J. [5 ,6 ]
Kandala, S. [7 ]
Pricop, L. [8 ]
Mpofu, S. [9 ]
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Guys & St Thomas NHS Fdn Trust, London, England
[4] Univ Glasgow, Glasgow, Lanark, Scotland
[5] Albany Med Coll, Albany, NY 12208 USA
[6] Ctr Rheumatol, New York, NY USA
[7] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[8] Novartis Pharmaceut, Orange, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2015年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P115
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [41] Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study
    Tahir, Hasan
    Deodhar, Atul
    Genovese, Mark
    Takeuchi, Tsutomu
    Aelion, Jacob
    Van den Bosch, Filip
    Haemmerle, Sibylle
    Richards, Hanno B.
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 475 - 488
  • [42] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth C.
    LANCET, 2018, 391 (10136): : 2213 - 2224
  • [43] USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE III, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY
    McInnes, Iain
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie
    RHEUMATOLOGY, 2013, 52 : 164 - 164
  • [44] Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study.
    Kavanaugh, Arthur
    Puig Sanz, Lluis
    Gottlieb, Alice B.
    Ritchlin, Christopher T.
    You, Yin
    Wang, Yuhua
    Mendelsohn, Alan M.
    Song, Michael
    Rahman, Proton
    McInnes, Iain B.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S234 - S234
  • [45] Ustekinumab in Active Psoriatic Arthritis Including Patients Previously Treated with Anti-TNF Agents: Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Ritchlin, Christopher T.
    Gottlieb, Alice B.
    McInnes, Iain B.
    Puig, Lluis
    Rahman, Proton
    Li, Shu
    Wang, Yuhua
    Doyle, Mittie K.
    Mendelsohn, Alan
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1080 - S1081
  • [46] Chinese Medicine Shensongyangxin Is Effective for Patients with Bradycardia: Results of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial
    Liu, Yunfang
    Li, Ning
    Jia, Zhenhua
    Lu, Feng
    Pu, Jielin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [47] Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Steinfeld, SD
    Choy, EHS
    Sharp, JT
    Ory, PA
    Perdok, RJ
    Weinberg, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3279 - 3289
  • [48] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
    Nash, Peter
    Mease, Philip J.
    McInnes, Iain B.
    Rahman, Proton
    Ritchlin, Christopher T.
    Blanco, Ricardo
    Dokoupilova, Eva
    Andersson, Mats
    Kajekar, Radhika
    Mpofu, Shephard
    Pricop, Luminita
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [49] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
    Peter Nash
    Philip J. Mease
    Iain B. McInnes
    Proton Rahman
    Christopher T. Ritchlin
    Ricardo Blanco
    Eva Dokoupilova
    Mats Andersson
    Radhika Kajekar
    Shephard Mpofu
    Luminita Pricop
    Arthritis Research & Therapy, 20
  • [50] Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
    Hawker, Kathleen
    O'Connor, Paul
    Freedman, Mark S.
    Calabresi, Peter A.
    Antel, Jack
    Simon, Jack
    Hauser, Stephen
    Waubant, Emmanuelle
    Vollmer, Timothy
    Panitch, Hillel
    Zhang, Jiameng
    Chin, Peter
    Smith, Craig H.
    ANNALS OF NEUROLOGY, 2009, 66 (04) : 460 - 471
12345